« Second death may doom multiple sclerosis drug | Main | Elan shares dive on drug setback »

Serono plans multiple sclerosis treatment by inhalation

Yaaaaa!

Serono of Switzerland is planning to expand its billion dollar multiple sclerosis franchise with a new version of interferon beta that would do away with the need for injections, reports Phil Taylor.


The company already sells an injectable drug for MS, Rebif (interferon beta 1a) and has small molecule, orally active drugs in its pipeline. These could now been joined by an inhaleable formulation that would provide a more patient-friendly alternative to the current injectable drugs for MS, and could improve efficacy.

Inhale here.

March 31, 2005 in rebif, research, treatment, worth following... | Permalink

Comments